Pantoprazole Injection Manufacturer in India

WHO-GMP certified sterile manufacturing of Pantoprazole 40mg dry powder injection — for acute acid suppression in hospitalised patients with gastric ulcer, GERD and stress ulcer prophylaxis.

Key Highlights

  • Pantoprazole Sodium 40mg
    · Dry powder vial

  • WHO-GMP Certified
    · Sterile Cleanroom

  • DCGI Approved
    Export-Ready

Product Details

Pantoprazole Injection — manufactured at 9M India

 

Product Specifications

  • Generic Name: Pantoprazole Sodium Sesquihydrate
  • Strength: 40mg (as Pantoprazole)
  • Dosage Form: Powder for Solution for Injection or Infusion
  • Route: Intravenous (IV)
  • Container: Type I glass vial — 10mL
  • Closure: Rubber stopper + aluminium flip-off crimp seal
  • Storage: Store below 25°C · Protect from light · After reconstitution: use immediately
  • Shelf Life: 24 months
  • Manufacturing: WHO-GMP certified sterile cleanroom · Grade A/B aseptic fill-finish
  • Regulatory Status: DCGI approved · Manufacturing licence held
  • Available For: Contract manufacturing · Third-party manufacturing · Direct supply

Pantoprazole IV is the most widely prescribed intravenous proton pump inhibitor — used for acute management of peptic ulcer disease, GI bleeding prophylaxis, GERD in patients unable to take oral medications, and stress ulcer prophylaxis in critically ill patients. On the WHO Essential Medicines List. Among the highest-volume dry powder injectables tendered by government hospitals and institutional buyers in India and export markets.

Enquire Now

    Manufacturing & Compliance

    How Pantoprazole Injection is manufactured at 9M India

    • Sterile cleanroom manufacture

      Pantoprazole Sodium solution is prepared under controlled pH (>10.5 to maintain stability), sterile-filtered and aseptically filled into Type I glass vials. Lyophilised (freeze-dried) under validated freeze-drying cycles to produce a white/off-white cake. The lyophilised product is sealed under nitrogen atmosphere to prevent oxidation. Reconstitution studies validated at 0.9% Sodium Chloride and 5% Dextrose.

    • In-house QC release testing — every batch

      Sterility · Bacterial endotoxins (<0.25 EU/mg) · Appearance of cake · Reconstitution time and clarity · pH of reconstituted solution (9.0–11.0) · Assay by HPLC (95.0–105.0%) · Related substances · Water content by Karl Fischer (<3.0%) — all in-house. COA per batch.

    • Documentation available within 24 hours

      DCGI manufacturing licence · WHO-GMP Certificate · Certificate of Analysis · Certificate of Conformance · Stability data (real-time and accelerated, ICH-aligned) · Batch manufacturing record summary — pre-prepared and available within 24 hours for tender submission, export registration or CDMO due diligence.

    Need Pantoprazole injection manufactured under your brand?

    Share your volume requirement and target market. We confirm manufacturing capability and documentation within 24 hours.

    • WHO-GMP
      Certified

    • DCGI
      Approved

    • In-House
      QC

    • Contract & 3PM
      Available

    Looking for something specific?

    At 9M India Limited, trust through quality, transparency, performance.